TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
-1.47%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$109B
AUM Growth
-$10.2B
(-8.5%)
Cap. Flow
-$4.91B
Cap. Flow
% of AUM
-4.5%
Top 10 Holdings %
Top 10 Hldgs %
29.03%
Holding
1,546
New
53
Increased
403
Reduced
866
Closed
64
Top Buys
| 1 |
SPDR Gold Trust
GLD
|
+$251M |
| 2 |
Financial Select Sector SPDR Fund
XLF
|
+$212M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$186M |
| 4 |
CME Group
CME
|
+$163M |
| 5 |
Snowflake
SNOW
|
+$102M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.3B |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$425M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$242M |
| 4 |
Amazon
AMZN
|
+$235M |
| 5 |
Blackrock
BLK
|
+$169M |
Sector Composition
| 1 | Financials | 19.44% |
| 2 | Technology | 18.74% |
| 3 | Healthcare | 9.11% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCLE
826
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
| $4.92M | ﹤0.01% |
500,000
| – | – |
|
827
John B. Sanfilippo & Son
JBSS
$724M
| $4.91M | ﹤0.01% |
58,800
| – | – |
|
828
Employers Holdings
EIG
$982M
| $4.89M | ﹤0.01% |
119,200
-11,200
| -9% | -$459K |
|
829
Zentalis Pharmaceuticals
ZNTL
$105M
| $4.89M | ﹤0.01% |
105,903
-11,730
| -10% | -$541K |
|
|
LCAA
830
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
| $4.88M | ﹤0.01% |
500,000
| – | – |
|
|
HAAC
831
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
| $4.87M | ﹤0.01% |
493,900
+159,300
| +48% | +$1.57M |
|
832
Las Vegas Sands
LVS
$37.4B
| $4.86M | ﹤0.01% |
125,116
-588
| -0.5% | -$22.9K |
|
833
Idacorp
IDA
$6.76B
| $4.84M | ﹤0.01% |
41,986
-6,208
| -13% | -$716K |
|
834
Horace Mann Educators
HMN
$1.89B
| $4.77M | ﹤0.01% |
114,050
-18,600
| -14% | -$778K |
|
835
10x Genomics
TXG
$1.57B
| $4.76M | ﹤0.01% |
62,533
+2,538
| +4% | +$193K |
|
836
Prothena Corp
PRTA
$447M
| $4.72M | ﹤0.01% |
129,141
-34,076
| -21% | -$1.25M |
|
837
Viatris
VTRS
$11.9B
| $4.67M | ﹤0.01% |
429,392
-214
| -0% | -$2.33K |
|
838
C.H. Robinson
CHRW
$15.1B
| $4.59M | ﹤0.01% |
42,622
-353
| -0.8% | -$38K |
|
839
Coca-Cola Consolidated
COKE
$10.5B
| $4.59M | ﹤0.01% |
92,360
+20,360
| +28% | +$1.01M |
|
840
IAMGOLD
IAG
$6.27B
| $4.59M | ﹤0.01% |
1,320,481
-149,011
| -10% | -$518K |
|
841
Lantheus
LNTH
$3.57B
| $4.57M | ﹤0.01% |
82,527
+6,293
| +8% | +$348K |
|
842
Fate Therapeutics
FATE
$115M
| $4.56M | ﹤0.01% |
117,580
+10,899
| +10% | +$423K |
|
|
JBTM
843
JBT Marel Corporation
JBTM
$7.09B
| $4.55M | ﹤0.01% |
38,414
-11,052
| -22% | -$1.31M |
|
|
ONC
844
BeOne Medicines Ltd. American Depositary Shares
ONC
$34.5B
| $4.52M | ﹤0.01% |
23,965
-561
| -2% | -$106K |
|
845
Alibaba
BABA
$343B
| $4.5M | ﹤0.01% |
41,395
-6,039
| -13% | -$657K |
|
846
PennyMac Financial
PFSI
$6.22B
| $4.49M | ﹤0.01% |
84,424
-5,558
| -6% | -$296K |
|
847
Outset Medical
OM
$241M
| $4.45M | ﹤0.01% |
6,529
+411
| +7% | +$280K |
|
848
Booz Allen Hamilton
BAH
$12.6B
| $4.41M | ﹤0.01% |
50,234
-26,028
| -34% | -$2.29M |
|
849
Guardant Health
GH
$7.05B
| $4.4M | ﹤0.01% |
66,442
+1,105
| +2% | +$73.2K |
|
|
EOCW
850
DELISTED
Elliott Opportunity II Corp.
EOCW
| $4.4M | ﹤0.01% |
450,000
| – | – |
|